We are live on ! Find out more
LPCN icon

Lipocine
LPCN

39 hedge funds and large institutions have $10.5M invested in Lipocine in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

676% more call options, than puts

Call options by funds: $1.11M | Put options by funds: $143K

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

5% more capital invested

Capital invested by funds: $10M → $10.5M (+$506K)

3% more funds holding

Funds holding: 38 → 39 (+1)

0.1% more ownership

Funds ownership: 0.61% → 0.71% (+0.1%)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
39
Holders Change
+1
Holders Change %
+2.63%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
12
Closed
7
Calls
$1.11M
Puts
$143K
Net Calls
+$966K
Net Calls Change
-$487K

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$137K
2
GCP
GSA Capital Partners
United Kingdom
+$137K
3
Two Sigma Investments
Two Sigma Investments
New York
+$112K
4
VF
Virtu Financial
New York
+$95.5K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$57.9K

Top Sellers

1
Ameriprise
Ameriprise
Minnesota
-$371K
2
Morgan Stanley
Morgan Stanley
New York
-$213K
3
XT
XTX Topco
Cayman Islands
-$31K
4
Barclays
Barclays
United Kingdom
-$26K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$26K
Name Holding Trade Value Shares
Change 		Change in
Stake
PMFA
26
Plante Moran Financial Advisors
Michigan
$17K +$18.6K +1,000 New
PPW
27
Pinnacle Private Wealth
Massachusetts
$15K +$16.7K +897 New
Goldman Sachs
28
Goldman Sachs
New York
$14K +$15.5K +835 New
ECM
29
ExodusPoint Capital Management
New York
$12K -$12K -644 -48%
CG
30
Cutler Group
California
$12K – – –
Creative Planning
31
Creative Planning
Kansas
$10K – – –
Wells Fargo
32
Wells Fargo
California
$5K – – –
UBS Group
33
UBS Group
Switzerland
$4K +$2.1K +113 +93%
TRCT
34
Tower Research Capital (TRC)
New York
$3K -$5.46K -294 -66%
JP Morgan Chase
35
JP Morgan Chase
New York
$3K – – –
Osaic Holdings
36
Osaic Holdings
Arizona
$1K -$16.2K -871 -91%
Bank of America
37
Bank of America
North Carolina
$1K -$1.08K -58 -46%
BFEC
38
Benjamin F. Edwards & Company
Missouri
$1K – – –
XT
39
XTX Topco
Cayman Islands
– -$31K -1,692 Closed
Barclays
40
Barclays
United Kingdom
– -$26K -1,416 Closed
Qube Research & Technologies (QRT)
41
Qube Research & Technologies (QRT)
United Kingdom
– -$26K -1,416 Closed
Principal Financial Group
42
Principal Financial Group
Iowa
– -$19K -1,032 Closed
SWA
43
Sutton Wealth Advisors
Florida
– -$1.09K -59 Closed
GWMIA
44
Global Wealth Management Investment Advisory
Florida
– -$1K -29 Closed
PWM
45
Prentice Wealth Management
New York
– -$1K -15 Closed
1
2

LPCN Hedge Fund Activity: Q4 2021 in Review

39 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q4 2021, worth a combined $10.5M — up 5.1% from $10M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new LPCN positions and 7 closed out — a net gain of 1 holder — while 7 added to existing stakes and 12 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $137K. The largest seller was Ameriprise, cutting an estimated $371K.

  • 39 institutional investors held Lipocine (LPCN) as of Q4 2021, up from 38 in Q3 2021.
  • Funds reported $10.5M of Lipocine stock for Q4 2021, up 5.1% quarter-over-quarter.
  • 8 funds opened new Lipocine positions in Q4 2021 and 7 closed out, a net change of +1 holder.
  • The largest Lipocine buyer in Q4 2021 was Susquehanna International Group, an estimated $137K added.
  • The largest Lipocine seller in Q4 2021 was Ameriprise, an estimated $371K sold.

Based on aggregated 13F filings for Q4 2021.